15.27
-0.63 (-3.96%)
| Previous Close | 15.90 |
| Open | 15.98 |
| Volume | 245,245 |
| Avg. Volume (3M) | 306,005 |
| Market Cap | 574,474,688 |
| Price / Sales | 11.15 |
| Price / Book | 2.43 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2026 |
| Diluted EPS (TTM) | -2.49 |
| Total Debt/Equity (MRQ) | 3.25% |
| Current Ratio (MRQ) | 21.47 |
| Operating Cash Flow (TTM) | -39.28 M |
| Levered Free Cash Flow (TTM) | -26.34 M |
| Return on Assets (TTM) | -22.95% |
| Return on Equity (TTM) | -33.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Contineum Therapeutics, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -3.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | 0.17 |
|
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.82% |
| % Held by Institutions | 79.99% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |